Current Edition

BIO

Upstream Bio, a richly funded startup, reveals its lead drug and research plans

An inflammatory disease drug cast aside by Astellas Pharma has a new owner in Upstream Bio, an emerging biotechnology startup led by industry veteran Samantha …

Continue Reading →
BIO

Solid Bio joins slate of biotech layoffs, shedding 35% of its workforce

Dive Brief: Gene therapy developer Solid Biosciences is laying off 35% of its employees, announcing Wednesday a plan to extend its current funds for another …

Continue Reading →
BIO

BIO18: Pfizer (sort of) inches back to neuro; Building ties with FDA

Three days into the BIO International convention, the industry group touted breaking the Guinness World Record for the largest business partnering meeting. BIO is hoping …

Continue Reading →